Cargando…
Abstract 129: Continuous glucose monitoring in type 2 diabetes mellitus to assess glycemic control and glycemic variability
Background: Continuous glucose monitoring (CGM) can provide information beyond HbA1c and SMBG for glycemic control. Objectives: To assess glycemic variability (GV) and correlation of CGM metrics with HbA1c in type 2 diabetic (T2DM) individuals. Results: We enrolled 54 T2DM patients (age 53±7.8 years...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067792/ http://dx.doi.org/10.4103/2230-8210.342254 |
Ejemplares similares
-
Abstract 93: Ambulatory glucose profiles of children and adolescents with T1DM: Identification of factors affecting glycemic control
por: Tandon, Ambica, et al.
Publicado: (2022) -
Abstract 25: Glycemic variability of oral semaglutide versus empagliflozin: A post hoc analysis of PIONEER 2
por: Shabeer, D, et al.
Publicado: (2022) -
Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
por: Singal, Arbinder, et al.
Publicado: (2022) -
Abstract 15: Glycemic and body weight responses to oral semaglutide in the PIONEER trial program
por: Kumar, K B Sharan, et al.
Publicado: (2022) -
Abstract 110: Prevalence of asymptomatic bacteriuria in patients with type 2 diabetes mellitus
por: Kolli, Sumanas Gopal Datta, et al.
Publicado: (2022)